Digistain® Email Formats

Biotechnology Research • Unit 101, Interchange Business Park, United Kingdom • 11-20 Employees

Digistain® Email Formats

Digistain® uses 2 email formats. The most common is {first initial} (e.g., j@digistain.co.uk), used 50% of the time.

Format	Example	Percentage
{first initial}	j@digistain.co.uk	50%
{first name}	john@digistain.co.uk	50%

Key Contacts at Digistain®

Hemmel Amrania Phd Breast Cancer Dia

Chief Executive Officer

Nen Nenchev

Chief Technology Officer

Company overview

Headquarters	Unit 101, Interchange Business Park,, Howard Way,, Newport Pagnell, , MK16 9PY, GB
Phone number	+442039519812
Website	digistain.co.uk
NAICS	541714
Employees	11-20
Socials

About Digistain®

Digistain ® - Leading digital transformation in cancer diagnostics - radically faster gold standard risk scoring analytics at a dramatically lower cost A Digital Solution To Cancer Grading And Prognosis approved by the UK’s Medicines & Healthcare products Regulatory Agency (MHRA), DIGISTAIN® is a patented risk profiling test for hormone receptor-positive breast cancer patients. Digistain’s easy-to-read report provides both physician and patient clear actionable information to help determine the best course of treatment and indeed whether cytotoxic therapy in addition to hormone therapy is required. The MHRA approved DIGISTAIN technology is based on 15 years of research and development pioneered by respected cancer research scientists at Imperial College with Professor Chris Phillips of the Biomedical Optics Division and Cancer Research UK (CRUK) with Professor Sir Nicholas Wright of Barts Hospital London, Head of Histopathology at CRUK and ex-president of the Pathological Society of Great Britain.